how many people are on glp 1 Poll: in 8 Adults Say They Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Poll: 1 in 8 Adults

Health 39 (1), 9098

These investigations are intended to detect trends, not definitive outcomes

According to the Navadhi Global Peptide Therapy Market Strategic Research Report 2026-2031 Asia-Pacific is the fastest-growing region at 17.07% CAGR, driven by China's 140 million diabetics, Japan's post-PMDA approvals of Ozempic and Wegovy, and India emerging as the fastest-growing sub-market at 19.89% CAGR, leveraging GLP-1 biosimilar production

Antihypertensive effect of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists

only the volume changes

Biol Plant 61:169177 Marrs KA, Walbot V (1997) Expression and RNA splicing of the maize glutathione S-transferase Bronze2 gene is regulated by cadmium and other stresses